X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6906) 6906
Publication (432) 432
Book Review (102) 102
Newsletter (55) 55
Magazine Article (46) 46
Book Chapter (38) 38
Newspaper Article (15) 15
Trade Publication Article (11) 11
Conference Proceeding (8) 8
Data Set (2) 2
Dissertation (2) 2
Book / eBook (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dabigatran (5372) 5372
humans (4306) 4306
index medicus (3916) 3916
warfarin (3140) 3140
rivaroxaban (2724) 2724
anticoagulants (2320) 2320
atrial fibrillation (2260) 2260
anticoagulants - therapeutic use (1783) 1783
apixaban (1776) 1776
male (1733) 1733
stroke (1611) 1611
female (1591) 1591
dabigatran etexilate (1511) 1511
administration, oral (1500) 1500
aged (1481) 1481
atrial fibrillation - drug therapy (1378) 1378
anticoagulants - adverse effects (1328) 1328
anticoagulants - administration & dosage (1305) 1305
cardiac & cardiovascular systems (1284) 1284
stroke - prevention & control (1132) 1132
atrial-fibrillation (1081) 1081
peripheral vascular disease (1079) 1079
prevention (1069) 1069
beta-alanine - analogs & derivatives (1046) 1046
hematology (1046) 1046
middle aged (979) 979
venous thromboembolism (979) 979
hemorrhage - chemically induced (964) 964
atrial fibrillation - complications (955) 955
risk factors (927) 927
benzimidazoles - therapeutic use (855) 855
treatment outcome (848) 848
thromboembolism (811) 811
management (799) 799
medicine, general & internal (796) 796
anticoagulation (779) 779
aged, 80 and over (754) 754
pharmacology & pharmacy (754) 754
safety (747) 747
risk (743) 743
warfarin - therapeutic use (723) 723
stroke prevention (719) 719
therapy (683) 683
oral anticoagulants (656) 656
benzimidazoles - adverse effects (631) 631
thrombin (625) 625
stroke - etiology (609) 609
abridged index medicus (600) 600
bleeding (596) 596
beta-alanine - therapeutic use (564) 564
direct thrombin inhibitor (563) 563
analysis (540) 540
drug therapy (529) 529
benzimidazoles - administration & dosage (525) 525
pyridones - therapeutic use (520) 520
pyrazoles - therapeutic use (519) 519
care and treatment (517) 517
hemorrhage (516) 516
dabigatran - therapeutic use (505) 505
antithrombins - therapeutic use (498) 498
medicine & public health (497) 497
cardiac arrhythmia (496) 496
antithrombins - adverse effects (488) 488
edoxaban (488) 488
warfarin - adverse effects (479) 479
beta-alanine - adverse effects (462) 462
dabigatran - adverse effects (450) 450
efficacy (449) 449
blood coagulation - drug effects (448) 448
thrombosis (437) 437
vitamin k - antagonists & inhibitors (430) 430
pyridines - therapeutic use (425) 425
dosage and administration (424) 424
pharmacokinetics (418) 418
surgery (405) 405
cardiology (402) 402
direct oral anticoagulants (395) 395
retrospective studies (393) 393
thiophenes - therapeutic use (390) 390
morpholines - therapeutic use (389) 389
patients (388) 388
dabigatran - administration & dosage (384) 384
metaanalysis (384) 384
warfarin - administration & dosage (379) 379
antithrombotic therapy (376) 376
thromboembolism - prevention & control (374) 374
antithrombins - administration & dosage (372) 372
adult (369) 369
mortality (369) 369
reversal (368) 368
enoxaparin (363) 363
risk assessment (357) 357
venous thromboembolism - prevention & control (356) 356
double-blind (352) 352
beta-alanine - administration & dosage (351) 351
factor xa inhibitors (344) 344
internal medicine (340) 340
pyrazoles - administration & dosage (335) 335
pyridones - administration & dosage (334) 334
aspirin (331) 331
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6050) 6050
German (277) 277
Spanish (198) 198
French (193) 193
Russian (84) 84
Japanese (44) 44
Czech (42) 42
Portuguese (25) 25
Polish (24) 24
Italian (23) 23
Hungarian (22) 22
Swedish (13) 13
Danish (12) 12
Turkish (10) 10
Chinese (5) 5
Dutch (5) 5
Slovenian (5) 5
Finnish (4) 4
Korean (4) 4
Norwegian (4) 4
Slovak (2) 2
Arabic (1) 1
Estonian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4814 - 4814
Abstract Introduction: MM pts have one of the highest risks of TE among cancer pts. Use of IMiDs plus dex further increases this risk. Guidelines recommend... 
Journal Article
BLOOD, ISSN 0006-4971, 09/2014, Volume 124, Issue 12, pp. 1968 - 1975
In the last 4 years, 6 phase 3 trials including a total of 27 023 patients with venous thromboembolism (VTE) compared a direct oral anticoagulant (DOAC) with... 
DABIGATRAN | METAANALYSIS | EFFICACY | WARFARIN | SAFETY | RIVAROXABAN | HEMATOLOGY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 5, pp. 431 - 441
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 03/2018, Volume 16, Issue 3, pp. 180 - 184
Journal Article
BLOOD, ISSN 0006-4971, 10/2017, Volume 130, Issue 15, pp. 1706 - 1712
There is uncertainty regarding the effectiveness and occurrence of thromboembolic events in patients treated with prothrombin complex concentrates (PCCs) for... 
ANTICOAGULANT | ORAL RIVAROXABAN | DABIGATRAN | HEMATOLOGY | WARFARIN | REVERSAL
Journal Article
by Yip, L and Deng, JF
AMERICAN JOURNAL OF KIDNEY DISEASES, ISSN 0272-6386, 01/2018, Volume 71, Issue 1, pp. 146 - 146
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 17, pp. 1627 - 1636
Journal Article